HowardGWoldMD

Oncology • Alexandria, LA

Physician

Join to view full profile

Dr. Wold is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Wold's full profile

Already have an account?

Office
605b Medical Center Dr
Alexandria, LA 71301
Phone+1 318-442-2232

Fax+1 318-442-2192
Is this information wrong?

Education & Training

Letterman Army Medical CenterFellowship, Hematology and Medical Oncology, 1981 - 1984
Letterman Army Medical CenterResidency, Internal Medicine, 1977 - 1980
West Virginia University School of MedicineClass of 1977

Certifications & Licensure

LA State Medical License 1988 - 2025
CA State Medical License 1979 - 2023
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc., 2012-2013

Publications & Presentations

PubMed

5 citations
Consolidation hemibody radiotherapy following induction combination chemotherapy in high-tumor-burden multiple myeloma.
M R MacKenzie, Howard G. Wold, Christopher B. George, David R. Gandara, G Ray, S Schiff, J Shields, R Artim, H Davidson, Frederick J. Meyers> ;Journal of Clinical Oncology. 1992 Nov 1
11 citations
High-dose cisplatin and mitomycin C in advanced non-small cell lung cancer: a phase II study of the Northern California Oncology Group.
David R. Gandara, Edith A. Perez, Howard G. Wold, Vincent Caggiano, Mary Malec, David K. Ahn, Frederick J. Meyers, Robert W. Carlson> ;Cancer Chemotherapy and Pharmacology. 1990 Jan 1
63 citations
Cisplatin Dose Intensity in Non-Small Cell Lung Cancer: Phase II Results of a Day 1 and Day 8 High-Dose Regimen
David R. Gandara, Howard G. Wold, Edith A. Perez, Albert B. Deisseroth, James H. Doroshow, Frederick J. Meyers, K. Mcwhirter, John F. Hannigan, Michael W. De Gregorio> ;Journal of the National Cancer Institute. 1989 May 22
15 citations
High-dose cisplatin with diethyldithiocarbamate (DDTC) rescue therapy: preliminary pharmacologic observations.
Michael W. DeGregorio, David R. Gandara, Walter M. Holleran, Edith A. Perez, Charles C. King, Howard G. Wold, Thomas J. Montine, Richard F. Borch> ;Cancer Chemotherapy and Pharmacology. 1989 Jan 1
49 citations
High-dose cisplatin in hypertonic saline: reduced toxicity of a modified dose schedule and correlation with plasma pharmacokinetics. A Northern California Oncology Gro...
David R. Gandara, Michael W. DeGregorio, Howard G. Wold, B. J. Wilbur, Marsha Kohler, H. J. Lawrence, Albert B. Deisseroth, Christopher B. George> ;Journal of Clinical Oncology. 1986 Dec 1
10 citations
Dose-limiting myelosuppression associated with high-dose cisplatin (200 mg/m2) in hypertonic saline.
David R. Gandara, Richard P. Mansour, Howard G. Wold, Christopher B. George> ;Cancer Treatment Reports. 1986 Jun 1
4 citations
Prednimustine in refractory non-Hodgkin's lymphoma: a phase II study of the Northern California Oncology Group.
David R. Gandara, Howard G. Wold, John Redmond, Marsha Kohler, Ralph Reynolds, Peter P. Wong, James Forsythe, Karen Fisher, Brian Lewis> ;Seminars in Oncology. 1986 Mar 1
6 citations
Prolymphocytic leukemia: serial responses to therapy
James F. Swift, Howard G. Wold, David R. Gandara, John Redmond, Christopher B. George> ;Cancer. 1984 Sep 15
Join now to see all